Results of phase II/IIIa paediatric study of once-weekly recombinant human growth hormone (rhGH) LB03002 are published in JCEM (Péter et al., JCEM 2012, 97(2):400-407)).

Results of phase II/IIIa paediatric study of once-weekly recombinant human growth hormone (rhGH) LB03002 are published in the Journal of Clinical Endocrinology and Metabolism (J Clin Endocrinol Metab, February 2012, 97(2):400-407)). The results show that LB03002 at doses of 0.5 mg/kg/week and 0.7 mg/kg/week is safe and effective in children with GH deficiency.

Please click here to read the study.